Sungcad, Floremie T.
HRN: 20-20-50 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/04/2026
AMPICILLIN 250MG (VIAL)
03/04/2026
03/11/2026
IV
2g
Q6
Nka
Checking Initial Appropriateness
03/04/2026
CEFUROXIME 500MG (TAB)
03/04/2026
03/11/2026
PO
1 Tab
BID
PROM
Checking Initial Appropriateness